Literature DB >> 5289716

Trials of intranasally administered rubella vaccine.

I B Hillary.   

Abstract

No evidence of vaccine virus transmission was found in two studies where Wistar RA 27/3 rubella vaccine was administered intranasally. Vaccine was immunogenic in all of 23 vaccinated children in one study, while in the other only 5 of the 11 vaccinees developed antibody. The reduced seroconversion rate in the latter study appears to have been caused by one or a combination of factors, including the vaccination technique, the presence of infective nasal conditions in vaccinees and the titre of vaccine used.

Entities:  

Mesh:

Substances:

Year:  1971        PMID: 5289716      PMCID: PMC2131036          DOI: 10.1017/s0022172400021811

Source DB:  PubMed          Journal:  J Hyg (Lond)        ISSN: 0022-1724


  11 in total

Review 1.  Some recent trends in vaccination against respiratory viruses.

Authors:  D A Tyrrell
Journal:  Br Med Bull       Date:  1969-05       Impact factor: 4.291

2.  The effect of kaolin on immunoglobulins: an improved technique to remove the nonspecific serum inhibitor of reovirus hemagglutination.

Authors:  J J Mann; R D Rossen; J R Lehrich; J A Kasel
Journal:  J Immunol       Date:  1967-06       Impact factor: 5.422

3.  Immunisation of schoolchildren with rubella (RA27-3) vaccine. Intranasal and subcutaneous administration.

Authors:  T H Ingalls; S A Plotkin; F R Philbrook; R F Thompson
Journal:  Lancet       Date:  1970-01-17       Impact factor: 79.321

4.  A simple method for removal of rubella hemagglutination inhibitors from serum adaptable to finger-tip blood.

Authors:  S A Plotkin; D J Bechtel; W D Sedwick
Journal:  Am J Epidemiol       Date:  1968-11       Impact factor: 4.897

5.  Clinical and serologic studies of an outbreak of rubella in a vaccinated population.

Authors:  T W Chang; S DesRosiers; L Weinstein
Journal:  N Engl J Med       Date:  1970-07-30       Impact factor: 91.245

6.  Rubella: reinfection of vaccinated and naturally immune persons exposed in an epidemic.

Authors:  D M Horstmann; H Liebhaber; G L Le Bouvier; D A Rosenberg; S B Halstead
Journal:  N Engl J Med       Date:  1970-10-08       Impact factor: 91.245

7.  Rubella vaccine trial in children.

Authors:  I B Hillary; P N Meenan; A H Griffith; C C Draper; G D Laurence
Journal:  Br Med J       Date:  1969-05-31

8.  Attenuation of RA 27-3 rubella virus in WI-38 human diploid cells.

Authors:  S A Plotkin; J D Farquhar; M Katz; F Buser
Journal:  Am J Dis Child       Date:  1969-08

9.  [The use of pigeon eruthrocytes in the hemagglutination inhibition test for rubella].

Authors:  J Peetermans; C Huygelen
Journal:  Presse Med       Date:  1967-10-21       Impact factor: 1.228

10.  Rubella-virus hemagglutination-inhibition test.

Authors:  G L Stewart; P D Parkman; H E Hopps; R D Douglas; J P Hamilton; H M Meyer
Journal:  N Engl J Med       Date:  1967-03-09       Impact factor: 91.245

View more
  4 in total

1.  WRL 105 strain live attenuated influenza vaccine; comparison of one and two dose schedules.

Authors:  A E Evans; E Letley; R D Ferris; D S Freestone
Journal:  J Hyg (Lond)       Date:  1976-12

Review 2.  Rubella vaccines: past, present and future.

Authors:  J M Best
Journal:  Epidemiol Infect       Date:  1991-08       Impact factor: 2.451

3.  The administration of drugs and vaccines by the intranasal route.

Authors:  D S Freestone; A L Weinberg
Journal:  Br J Clin Pharmacol       Date:  1976-10       Impact factor: 4.335

4.  Rubella vaccination.

Authors: 
Journal:  Br Med J       Date:  1972-08-05
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.